malondialdehyde has been researched along with 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T; Takahashi, K; Takebe, G; Uchida, K | 1 |
| Habazi, D; Han, J; Mohan, C; Saxena, R; Wu, T; Ye, Y; Zhang, T | 1 |
2 other study(ies) available for malondialdehyde and 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine
| Article | Year |
|---|---|
Rapid formation of 4-hydroxy-2-nonenal, malondialdehyde, and phosphatidylcholine aldehyde from phospholipid hydroperoxide by hemoproteins.
Topics: Aldehydes; Antioxidants; Deoxycholic Acid; Free Radicals; Hemeproteins; Hemoglobins; Hydrogen Peroxide; Lipid Metabolism; Lipid Peroxidation; Lipoproteins; Lipoxygenase; Malondialdehyde; Methemoglobin; Models, Chemical; Phosphatidylcholines; Phospholipid Ethers; Time Factors; Ultraviolet Rays; Ursodeoxycholic Acid | 2004 |
Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE.
Topics: Autoantibodies; Case-Control Studies; Complement C3; Complement C4; DNA; Humans; Immunoglobulin G; Immunoglobulin M; Linoleic Acids; Linoleic Acids, Conjugated; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Phospholipid Ethers; Severity of Illness Index | 2019 |